Hepatitis - Self-Learning Package Flashcards

1
Q

The most obvious sign of hepatitis

A

Jaundice with hepatic tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The most important causes of viral hepatitis in the UK

A

Hepatitis A, B, C and E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define subclinical illness

A

Infection with no symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define anicteric illness

A

Symptoms but no jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define icteric illness

A

Symptoms with jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define fulminant hepatitis

A

Severe jaundice with hepatic failure and high mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which enzymes will be raised in acute infection? (2)

A
Alanine aminotransferase (ALT)
Aspartate aminotransferase (AST)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common clinical presentation of hepatitis A virus (HAV) infection in children under 5 years old

A

Mild, often subclinical or anicteric presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mean incubation period of hepatitis A virus (HAV)

A

28 days (ranges from 10-50 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Common symptoms of hepatitis A virus (HAV) infection in adults (8)

A
Fever
Malaise
Anorexia
Nausea
Vomiting
Upper abdominal pain
Jaundice and dark coloured urine 3-10 days later
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main route of infection for hepatitis A virus (HAV)?

A

Faecal-oral

although faecal contaminated food or water may also play a part

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When are patients with hepatitis A virus (HAV) most infectious?

A

From a week before the onset of jaundice to a few days after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of antibodies are associated with hepatitis A virus (HAV) infection?

A

Anti-HAV IgM antibodies (usually present in serum from onset of symptoms to 3-6 months thereafter)
Anti-HAV IgA antibodies, which reflect immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the treatment for hepatitis A?

A

There is no specific treatment, only supportive management of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the three main methods of prevention of hepatitis A infection?

A

Good personal hygiene and sanitation
Human normal immunoglobulin (HNIG) - prophylaxis for close contacts of infected patients
Active immunisation (vaccine with killed virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the prognosis for hepatitis A?

A

Good - recovery can be slow but death from fulminant hepatitis is rare
There is no chronic infection or liver damage
Lifelong immunity follows infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the common symptoms of acute hepatitis B infection and when can they present? (9)

A
Anorexia
Lethargy
Nausea
Fever
Abdominal discomfort
Arthralgia
Urticarial skin lesions
Followed by jaundice and dark coloured urine

Can occur any time between a few weeks and 6 months after the initial infection

18
Q

What is the major serum marker for identifying hepatitis B virus?

A

HBsAg (hepatitis B surface antigen)

19
Q

What are the two main serum markers of viral replication of hepatitis B virus?

A

HBV-DNA (hepatitis B virus DNA)

HBeAg (hepatitis B “e” antigen - it is split off HBcAg (hepatitis B core antigen) during viral replication)

20
Q

Routes of transmission of hepatitis B virus (4)

A

Vertical: perinatal (from mother to child during birth)
Horizontal: sexual, parenteral (any method of transmission outside the digestive system) including needlestick injury, inapparent parenteral

21
Q

Why is hepatitis B virus so infectious?

A

It is stable and able to survive outside the human body for weeks

22
Q

What are some predisposing factors to increased risk of hepatitis B virus infection in the UK? (9)

A
  1. Injecting drug use
  2. Multiple sexual partners
  3. Immigration from high endemnicity areas
  4. Patients with learning disabilities who live in residential care
  5. Patients with haemophilia or on haemodialysis
  6. Sexual partners of those with the above risks
  7. Babies born to at-risk mothers
  8. Tattooing/piercing with non-sterile equipment
  9. Medical equipment if not adequately decontaminated
23
Q

How is the diagnosis of acute HBV infection made?

A
Serum HBsAg (unless patient presents very late or in severe fulminant acute disease)
Anti-HBc antibodies are present from the end of the illness onwards, so indicate a previous acute infection
24
Q

Clinical features of chronic HBV infection (5)

A

Persistence of HBsAg in the serum for more than 6 months
The risk of becoming chronically infected decreases with age
More common in males and immunocompromised patients
Previous mild or asymptomatic acute infection (due to defective cell-mediated immune response)
Jaundice is unusual

25
Q

Prognosis of chronic HBV infection

A

If left untreated, progression to chronic liver disease, and thus cirrhosis or hepatoma occurs in 25% of patients

(Less commonly, can also progress to membranous glomerulonephritis and polyarteritis nodosa)

26
Q

Treatment for chronic HBV infection

A

Entecavir or tenofovir - recommended over lamivudine, adefovir dipivoxil and telbivudine due to better efficacy and lower level of viral resistance
Liver transplantation

27
Q

Prevention of chronic hepatitis B infection (4)

A

Active immunisation with a vaccine containing HBsAg
Passive immunisation with hepatitis B specific immunoglobulin (HBIG) - usually in combination with the vaccine
Infection control procedures
Screening of blood and transplant donors

28
Q

Clinical features of hepatitis C

A

Acute infection:

  • usually subclinical or mild
  • vague symptoms of malaise, anorexia and fatigue in 20%.

Chronic infection:
- develops in 60-80%, but many have no symptoms

29
Q

Known routes of transmission of hepatitis C virus (HCV) (8)

A

(blood-borne virus)

  1. Shared “works” associated with intravenous drug use (IDU) including needles, syringes, filters, spoons
  2. Blood products prior to heat treatment in 1989
  3. Blood transfusion prior to antibody screening in 1991
  4. Tattooing, piercing or acupuncture with non-sterile equipment
  5. Sexual transmission (<5%)
  6. Mother-to-child
  7. Household contacts sharing razors or toothbrushes
  8. Medical/dental equipment if inadequately decontaminated
30
Q

Diagnostic tests available for hepatitis C virus (5)

A
IgG test - only of value if positive but even then, should be treated with caution
HCV antigen test (confirmatory)
HCV-RNA test (confirmatory)
Viral RNA
Sequencing for genotype
31
Q

Treatment of hepatitis C

A

A combination pegylated alpha-interferon and ribavirin (with the addition of an HCV protease-inhibiting drug if the virus is genotype 1)

32
Q

Name and describe the 4 types of response patterns to antiviral therapy

A

Non-responder - virus remains detectable despite therapy
Viral breakthrough - initial response followed by an increase in virus level by a factor of 10 (or 1 log unit)
Relapser - virus undetectable during therapy but detectable on stopping treatment
Sustained viral response - virus undetectable for 6 months after therapy

33
Q

How can hepatitis C be prevented? (3)

A

Avoiding contact with infected blood (i.e. avoiding all routes of transmission)
Blood, organ and tissue screening
Covering cuts and lesions with waterproof dressings

There is no prophylaxis or vaccine available!

34
Q

What is the prognosis for hepatitis C?

A

Of those with chronic HCV, 20-50% develop cirrhosis in 30 years

35
Q

Why is hepatitis D virus (HDV or Delta Hepatitis) termed a “defective” virus?

A

Because it is always found with hepatitis B virus, which appears to be essential for its transmission.

36
Q

What is the mean incubation period of hepatitis E virus (HEV)?

A

40 days (range: 3-8 weeks)

37
Q

What are the clinical features of hepatitis E in developing countries?

A

In developing countries, infection clinically resembles hepatitis A, but there is an increased incidence of fulminant hepatitis with high mortality in pregnant women.

38
Q

What are the clinical features of hepatitis E in developed countries?

A

Mild or subclinical in women and young people, but more severe in elderly men.
Liver failure may develop
Extra-hepatic features (arthritis, anaemia, neurological manifestations) may predominate over hepatic features.
In most cases, acute infection is self-limiting.

39
Q

What are the routes of transmission of hepatitis E virus (HEV)? (4)

A

Sewage-contaminated drinking water and probably food
Undercooked pork products (85% of pigs in the UK are infected)
Occupation related (e.g. abattoir workers)
Blood exposure

40
Q

Diagnostic tests for hepatitis E virus (HEV)

A

There are tests for IgG, IgM and HEV-RNA but it is not known if protective immunoglobulins develop against future infection

41
Q

Treatment for hepatitis E

A

No licensed treatment
In the immunocompromised, reduce immunosuppression if possible, but if not (or in severe infection), give ribavirin monotherapy

42
Q

What are the methods of prevention of hepatitis E?

A

Good hygiene
Good sanitation
Adequate cooking of food
Passive immunisation with human normal immunoglobulin (HNIG) - doesn’t protect tropical travellers

(Active immunisation with a subunit vaccine is available in China)